Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
CDPH/Health Update - June 15, 2026: There has been an increase in travel-related introductions of clade I mpox into California and the U.S. in 2026, and clade II mpox cases have increased in California. Increases in clade I community transmission in Western Europe suggest that additional travel-related clade I mpox cases should be expected in California. Clinicians should have a heightened index of suspicion for mpox and particularly for clade I mpox in individuals who report recent international travel or sexual or intimate contact with someone who recently traveled internationally, especially to an area where clade I is circulating. Providers and assistants including cleaning staff should wear full PPE (gloves, gown, goggles, and fit tested N-95 respirator). Mpox testing should be considered for patients with compatible signs and symptoms (PDF), regardless of vaccination status or previous infection. Providers should report suspect or confirmed clade I mpox cases immediately to their local health department and/or CDPH. Mpox vaccination with two doses is recommended for individuals who may be at risk for mpoxincluding immune compromised individuals and is expected to protect against both clade I and clade II mpox or any subclades.
